Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06266403 · ClinicalTrials.gov registry record · NA
Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications
A NA study of Amyotrophic Lateral Sclerosis, sponsored by Penn State University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06266403: Recruiting NA study of Amyotrophic Lateral Sclerosis, sponsored by Penn State University.
NCT06266403 is a NA study of Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Penn State University. The registered enrollment target is 300 participants, below the 895-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06266403, a NA study of Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and age-matched speakers. The question is, What are the effects of communicative interaction on verbal communication in people with ALS? Participants will read words and sentences while they are in a solo setting and interactive setting.
Primary Outcome
Formant frequencies that characterize speech sounds will be made on speech recorded in the intervention task.
Conditions Studied
Interventions
- BEHAVIORAL Structured Communicative Interaction
- BEHAVIORAL Clear Speech
- BEHAVIORAL Unstructured communicative interaction
- BEHAVIORAL Clear Speech Structured Communicative Interaction
Study Locations (1)
Pennsylvania
- Speech Core, Pennsylvania State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-11-05 |
| Est. Completion | 2029-02-28 |
| Phase | NA |
What NCT06266403 shows while recruiting
NCT06266403 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 895-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 4 interventions - of which Structured Communicative Interaction is the first listed.
NCT06266403 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06266403 about?
NCT06266403 is a clinical study titled "Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications". The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and age-matched speakers. The question is, What are the effects of communicative interaction on verbal communication in people with AL...
What is the current status of trial NCT06266403?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-11-05. Estimated completion is 2029-02-28.
What conditions does trial NCT06266403 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.
What interventions are being tested in trial NCT06266403?
The interventions under investigation include: Structured Communicative Interaction (BEHAVIORAL), Clear Speech (BEHAVIORAL), Unstructured communicative interaction (BEHAVIORAL), Clear Speech Structured Communicative Interaction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06266403?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06266403 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06266403's enrollment target sits among peer trials
300 26th of 102 higher than 77 of 102 other Amyotrophic Lateral Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALS
RECRUITING · NA
-
Precise Robotically IMplanted Brain-Computer InterfacE
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI